Home » Topics » BioWorld Science

BioWorld Science
RSS

New JAK-2 inhibitors identified at East China University of Science and Technology

Oct. 31, 2019

GlaxoSmithKline Biologicals presents new Toll-like receptor 7/8 agonists

Oct. 31, 2019

FDA approves Vumerity for the treatment of multiple sclerosis

Oct. 31, 2019

First patient dosed in phase II study of novel hepcidin mimetic PTG-300

Oct. 31, 2019

Shandong Luoxin Pharmacy Group and Luoxin Pharmaceutical (Shanghai) patent TLR7 agonists

Oct. 31, 2019

Bayer Pharma describes new kallikrein B inhibitors

Oct. 31, 2019

Cyclin-dependant kinase 7 inhibitors discovered by Lead Discovery Center and Qurient

Oct. 31, 2019

Preclinical evaluation of highly potent caspase-cleavable docetaxel prodrug, MPD-03

Oct. 31, 2019

INTH-454: A small molecule modulator of the p300/CBP interactome for cancer

Oct. 31, 2019

(R)-[18F]MH.MZ as a novel PET tracer for the detection of 5-HT2A receptors in the human brain

Oct. 31, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...